Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2012 15:02 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Fiscal 2011 Year Results

PHILADELPHIA, March 14, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced its financial results for the fiscal year ended December 31, 2011. The net loss for 2011's twelve month...
January 26, 2012 08:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Gains Regulatory Approval in Latin America

PHILADELPHIA, Jan. 26, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that ANMAT (Administracion Nacional de Medicamentos,...
January 17, 2012 08:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Receives U.S. Patent Office Notification of Two New Patents Granted for Alferon(R) LDO

PHILADELPHIA, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced today the granting of two new United States Patents for the use of...
January 11, 2012 08:30 ET | Source: Hemispherx Biopharma, Inc.

FDA Grants Hemispherx Biopharma Extension in Its Pending New Drug Application (NDA) for the Treatment of Chronic Fatigue Syndrome (CFS)

PHILADELPHIA, Jan. 11, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced today that the Food and Drug Administration ("FDA") granted an...
December 08, 2011 16:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's 2011 Stockholder Annual Meeting Final Results

PHILADELPHIA, Dec. 8, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") has concluded its 2011 Stockholder Annual Meeting with the passage of Proposal No. 4 to...
November 09, 2011 16:13 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Further Adjournment on Proposal Number 4 From the 2011 Annual Meeting of Stockholders

PHILADELPHIA, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced today that the Company will extend the time allowed for stockholders to vote on proposal number 4...
November 09, 2011 12:26 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2011

Operating Expenses Continue to be Reduced Construction at New Jersey Facility Underway New Clinical Trial Initiated PHILADELPHIA, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc....
October 24, 2011 10:22 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011

PHILADELPHIA, Oct. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex: HEB) (the "Company"), has scheduled a conference call and audio webcast on Thursday, October 27, 2011 at 2:00...
October 17, 2011 11:45 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Reports on Annual Stockholder Meeting

PHILADELPHIA, Oct. 17, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced that it held its 2011 Annual Meeting of Stockholders on October 13, 2011. Final voting results will be...
October 11, 2011 10:30 ET | Source: Hemispherx Biopharma, Inc.

2011 Nobel Prize Awarded for Discovery of Innate Immunity Pathways -- Research Included Studies on Experimental Drug in Hemispherx Biopharma Portfolio

PHILADELPHIA, Oct. 11, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) ("Hemispherx" or the "Company") offered congratulations and homage to Ralph M. Steinman (1943-2011) who...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right